The discussion was on Tuesday, December 7, 2021
Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy Monitoring
Speaker –
Adam Brufsky, MD, Ph.D.
Speaks about Navigating Treatment Decision Points in Management of TNBC: Interactive Case Studies